Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miR‑22‑3p enhances multi‑chemoresistance by targeting NET1 in bladder cancer cells

4 Apr 2018

Abstract excerpt

With the discovery of new chemotherapeutic drugs, chemotherapy becomes increasingly valuable. However, the resistance of tumor cells to chemotherapeutic agents significantly limits the effectiveness and causes chemotherapy failure. MicroRNAs have been shown to regulate drug resistance in many types of cancer. In the present study, we measured the chemosensitivity of five bladder cancer (BCa) cell lines to seven...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29620229
DOI: 10.3892/or.2018.6355

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miR‑22‑3p enhances multi‑chemoresistance by targeting NET1 in bladder cancer cellsPMID 29620229Read ↗

Management of advanced bladder cancer in the era of targeted therapies.Semantic proximity Read ↗

Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cellsSemantic proximity Read ↗

Predicting responses to platin chemotherapy agents with biochemically-inspired machine learningSemantic proximity Read ↗

Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancerSemantic proximity Read ↗

Doctors revise Declaration of HelsinkiSemantic proximity Read ↗

Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell linesSemantic proximity Read ↗

Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implicationsSemantic proximity Read ↗

Effects and mechanisms of AMIGO2 in proliferation, migration and drug resistance of bladder cancerSemantic proximity Read ↗

CircFAM114A2 Inhibits Bladder Cancer Proliferation and Promotes Cisplatin Sensitivity via the miR-222-3p/P27 and miR-146a-5p/P21 CascadesSemantic proximity Read ↗

Significance and Mechanisms Analyses of RB1 Mutation in Bladder Cancer Disease Progression and Drug Selection by Bioinformatics AnalysisSemantic proximity Read ↗

Predicting Response to Platin Chemotherapy Agents with Biochemically-inspired Machine LearningSemantic proximity Read ↗

The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.